UroGen Pharma Ltd. (URGN) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 1.13B |
| Enterprise Value | 1.14B |
| P/E Ratio | -19.18 |
| PEG Ratio | -0.18 |
| Price/Sales Ratio | 4.96 |
| Price/Book Ratio | -10.22 |
| Enterprise/Revenue | 5.4 |
| Enterprise/EBITDA | -33.91 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -0.26 |
| Operating Margin | -0.12 |
| Return On Assets | -0.24 |
| Return On Equity | 0.54 |
| Revenue | 109.79M |
| Revenue/Share | 4.95 |
| Gross Profit | 97.34M |
| EBITDA | -135.66M |
| Net Income | -153.49M |
| Diluted EPS | -3.19 |
| Total Cash | 90.55M |
| Total Cash/Share | 1.79 |
| Total Debt | 196.28M |
| Total Debt/Equity | -1.57 |
| Current Ratio | 3.4 |
| Book Value Per Share | -2.48 |
| 52-Week Change | 7.15 |
| 52-Week High | 50.81 |
| 52-Week Low | 16.5 |
| Moving Average 50 Days | 38.08 |
| Moving Average 200 Days | 31.61 |
| Average Volume | 1.02M |
| Shares Outstanding | 49.05M |
| % Held by Institutions | 84.47 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |